Ads
related to: t-cell therapy- T-Cell Engager Technology
See How Engaging T-Cells With DLL3
Can Play An Important Role In SCLC
- Using DLL3 Approaches
Targeting DLL3 Through T-cell
Engager Technology In SCLC
- About SC Lung Cancer
Oncologists: Discover The Potential
Of T-Cell Engager Technology
- Targeting DLL3
Learn About DLL3 Expression In
SCLC And Other NECs
- T-Cell Engager Technology
Search results
Strengthening CAR-T therapy to work against solid tumors
Medical Xpress· 2 days agoThe promising findings, reported in Science Advances, involve CAR-T cell therapy, which supercharges...
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical ...
GuruFocus.com via Yahoo Finance· 3 hours agoResearch and Development: Progress noted in clinical trials, including treatment of first patient in FT819 CAR T-cell therapy for autoimmunity ...
Can multiple myeloma be cured? Treatments and outlook
Medical News Today· 2 days agoConsolidation: This is only if a person is to receive a stem cell transplant. Maintenance: This...
Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
GuruFocus.com via Yahoo Finance· 5 hours agoInc (NASDAQ:IOVA), a trailblazer in the development of novel cancer treatments, disclosed its...
Acepodia reports preliminary results from ACE1831 Phase I trial
Clinical Trials Arena via Yahoo Finance· 1 day agoClinical-stage biotechnology company Acepodia has reported preliminary results from the Phase I...
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 23 hours agoAnito-cel, which utilizes Arcellx’s novel D-Domain binder, is a BCMA CAR T-cell therapy, a type of...
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoAnito-cel is a B-cell maturation antigen chimeric antigen receptor (BCMA CAR) T-cell therapy. The...
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem...
Newswise· 4 days ago(YCC) and Smilow Cancer Hospital (SCH) have again received an internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation ...
Identification of clinically relevant T cell receptors for personalized T cell therapy using...
Nature· 4 days agoTumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
AI predicts tumor-killing cells with high accuracy, study shows
Medical Xpress· 3 days agoCombined with additional algorithms, the predictive model, described in the current issue of the journal Nature Biotechnology, can be applied to personalized cancer treatments that tailor < ...